What's breaking now, across thousands of outlets.
(MedPage Today) -- The FDA is requiring manufacturers of all GLP-1 drugs to update their prescribing information to include a warning about the potential risk of non-arteritic anterior ischemic optic neuropathy (NAION), a rare but potentially blinding...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
For $550 million up front, Argenx will take control of Unnatural Products’ “macrocyclic peptide” technology and direct it to develop oral, durable medicines for serious immune-mediated diseases.
In part, funding was determined based on how states have implemented RHTP plans thus far.
The new facilities, dubbed Inspiration Tower and Prism, will make up nearly two million square feet.
Former President Biden on Sunday said he was scaling back the book tour for his upcoming presidential memoir due to his ongoing cancer diagnosis.
Some patients with autoimmune condition, taking part in trial, have been able to return to work and resume hobbies Doctors have made a potentially significant breakthrough in the hunt for a treatment…
A new study shows Delta’s five-minute boarding tweak boosted on-time departures by 32%.
